Scientists Screen for Pancreatic Cancer Using Artificial Intelligence
source: pixabay.com

Scientists Screen for Pancreatic Cancer Using Artificial Intelligence

  News-Medical Life Sciences recently interviewed Dr. Ananya Malhotra, Research Fellow at the London School of Hygiene, regarding her most current research involving pancreatic cancer. Dr. Malhotra believes artificial intelligence (AI)…

Continue Reading Scientists Screen for Pancreatic Cancer Using Artificial Intelligence
Study: Verdiperstat as a Treatment for Amyotrophic Lateral Sclerosis (ALS)
source: pixabay.com

Study: Verdiperstat as a Treatment for Amyotrophic Lateral Sclerosis (ALS)

The HEALY ALS Platform Trial, being conducted by Biohaven Pharma, has begun enrolling patients. This study is intended to test the efficacy of three treatments on amyotrophic lateral sclerosis (ALS),…

Continue Reading Study: Verdiperstat as a Treatment for Amyotrophic Lateral Sclerosis (ALS)
The Results from a Primary Biliary Cholangitis Trial Look Promising
source: pixabay.com

The Results from a Primary Biliary Cholangitis Trial Look Promising

According to a story from GlobeNewswire, the biopharmaceutical company CymaBay Therapeutics, Inc. recently announced encouraging topline findings from a phase 3 clinical trial. This study was testing seladelpar as a…

Continue Reading The Results from a Primary Biliary Cholangitis Trial Look Promising
This New Treatment for Mantle Cell Lymphoma has the Potential for Durable Remissions
source: pixabay.com

This New Treatment for Mantle Cell Lymphoma has the Potential for Durable Remissions

  A recent article in The American Journal of Managed Care (AJMC) heralds the approval of a third CAR T-cell therapy, called Tecartus. Kite Pharma’s cell-based gene therapy is the first…

Continue Reading This New Treatment for Mantle Cell Lymphoma has the Potential for Durable Remissions

Ovid Therapeutics and Columbia University are Working on a Treatment for KIF1A Associated Neurological Disorder

According to a story from GlobeNewswire, the biopharmaceutical company Ovid Therapeutics Inc. and Columbia University have recently entered a collaborative partnership that will be focused on developing gene-based treatments for…

Continue Reading Ovid Therapeutics and Columbia University are Working on a Treatment for KIF1A Associated Neurological Disorder
LQTS in Children is Potentially Lethal But Can Be Detected through ECG Assessment
source: pixabay.com

LQTS in Children is Potentially Lethal But Can Be Detected through ECG Assessment

  A recent article published in EMS WORLD cautions that long QT syndrome (LQTS), a potentially lethal disease in young people, often remains undiscovered. An ECG can detect the disease,…

Continue Reading LQTS in Children is Potentially Lethal But Can Be Detected through ECG Assessment
This New Treatment for Mantle Cell Lymphoma has the Potential for Durable Remissions
source: pixabay.com

This New Treatment for Mantle Cell Lymphoma has the Potential for Durable Remissions

  A recent article in The American Journal of Managed Care (AJMC) heralds the approval of a third CAR T-cell therapy, called Tecartus. Kite Pharma’s cell-based gene therapy is the first…

Continue Reading This New Treatment for Mantle Cell Lymphoma has the Potential for Durable Remissions
Duchenne Muscular Dystrophy: Two Patients with a Rare Mutation Were Just Dosed with Gene Therapy
source: pixabay.com

Duchenne Muscular Dystrophy: Two Patients with a Rare Mutation Were Just Dosed with Gene Therapy

According to a story from the CureDuchenne Blog, Dr. Kevin Flanigan of Nationwide Children's Hospital has recently dosed two Duchenne muscular dystrophy patients with an experimental gene therapy. This gene…

Continue Reading Duchenne Muscular Dystrophy: Two Patients with a Rare Mutation Were Just Dosed with Gene Therapy
Taking It One Step Further in the Quest to Prolong Survival in Acute Myeloid Leukemia
source: pixabay.com

Taking It One Step Further in the Quest to Prolong Survival in Acute Myeloid Leukemia

  Dr. Lindsay Wilde, an oncologist at the Hematologic Malignancies Division of Jefferson University, recently contributed to an article in the Oncology Times outlining her research team’s new study and…

Continue Reading Taking It One Step Further in the Quest to Prolong Survival in Acute Myeloid Leukemia
Studies from UCSF Offer New Perspective on Fibromyalgia and Chronic Fatigue Syndrome
source: pixabay.com

Studies from UCSF Offer New Perspective on Fibromyalgia and Chronic Fatigue Syndrome

  Researchers discovered surprising results after performing new studies of chronic fatigue syndrome (ME/CFS) and fibromyalgia (FM). According to a report by Cort Johnson in HealthRising, the new studies give…

Continue Reading Studies from UCSF Offer New Perspective on Fibromyalgia and Chronic Fatigue Syndrome
Rare Pediatric Disease Designation Given for Investigative Lymphatic Malformations Therapy
source: pixabay.com

Rare Pediatric Disease Designation Given for Investigative Lymphatic Malformations Therapy

Rare Pediatric Disease Designation has just been granted by the FDA for an investigative therapy for lymphatic malformations (LMs). This therapy is called TARA-002 and was developed by Protara Therapeutics.…

Continue Reading Rare Pediatric Disease Designation Given for Investigative Lymphatic Malformations Therapy